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H I G H L I G H T S
• Youth tobacco users were more likely to use alcohol or drugs compared to non-users.
• Youth tobacco users were more likely to have substance use and mental health problems.
• In particular, poly-tobacco use was strongly associated with substance use problems.
• Female tobacco users were more likely to have substance use and internalizing problems.
• Comprehensive interventions and treatments can effectively address youth comorbidities.







A B S T R A C T
Introduction: Cigarette use is associated with substance use and mental health problems among youth, but as-
sociations are unknown for non-cigarette tobacco product use, as well as the increasingly common poly-tobacco
use.
Methods: The current study examined co-occurrence of substance use and mental health problems across tobacco
products among 13,617 youth aged 12–17 years from Wave 1 (2013–2014) of the nationally representative
Population Assessment of Tobacco and Health (PATH) Study. Participants self-reported ever cigarette, e-cigar-
ette, smokeless tobacco, traditional cigar, cigarillo, filtered cigar, hookah, and other tobacco product use; al-
cohol, marijuana, and other drugs; and lifetime substance use, internalizing and externalizing problems.
Results: In multivariable regression analyses, use of each tobacco product was associated with substance use,
particularly cigarillos and marijuana (AOR = 18.9, 95% CI: 15.3–23.4). Cigarette (AOR = 14.7, 95% CI:
11.8–18.2) and cigarillo (AOR = 8.1, 95% CI: 6.3–10.3) use were strongly associated with substance use pro-
blems and tobacco users were more likely to report internalizing (AOR = 1.6, 95% CI: 1.4–1.8) and ex-
ternalizing (AOR = 1.4, 95% CI: 1.3–1.6) problems. Female tobacco users were more likely to have internalizing
problems than male tobacco users. Poly-tobacco users were more likely than exclusive users to use substances
(AOR = 3.4, 95% CI: 2.7–4.3) and have mental health (AOR = 1.2, 95% CI: 1.0–1.5) and substance use
(AOR = 4.7, 95% CI: 3.4–6.6) problems.
Conclusions: Regardless of the tobacco product used, findings reveal high co-occurrence of substance use and
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mental health problems among youth tobacco users, especially poly-tobacco users. These findings suggest the
need to address comorbidities among high risk youth in prevention and treatment settings.
1. Introduction
Although cigarette smoking has continually declined in the United
States, cigarette use remains common among youth (Arrazola et al.,
2015). Furthermore, national surveys show that use of non-cigarette
products such as e-cigarettes, hookah, little cigars, and smokeless to-
bacco has become increasingly common (Arrazola et al., 2015;
Johnston, O'Malley, Miech, Bachman, & Schulenberg, 2017; Kasza
et al., 2017; Y. O. Lee, Hebert, Nonnemaker, & Kim, 2015). Previous
research has found consistent associations with certain tobacco pro-
ducts (especially cigarettes), alcohol or drugs, and mental health pro-
blems among U.S. youth. No study to date has examined these asso-
ciations across tobacco products, addictive substances, and
internalizing and externalizing mental health problems in a nationally
representative sample. Moreover, approximately four in ten current
tobacco users report using two or more products (Kasza et al., 2017),
but scant research has examined the role of poly-tobacco use in these
associations.
While available research suggests that the strong association be-
tween cigarette use and substance use may extend across specific sub-
stances (Richter, Pugh, Smith, & Ball, 2017), this has never been ex-
amined in a systematic and comprehensive manner (Kandel,
Yamaguchi, & Chen, 1992). This literature is limited not only by a
narrow focus on alcohol and marijuana, but few studies focus on
emerging tobacco products, such as e-cigarettes, cigar types and
hookah, that are commonly used by American youth (Kasza et al.,
2017). Additionally, a 2012 review found high co-occurrence of to-
bacco (mostly cigarettes) and marijuana among youth and young adults
in the majority of cross-sectional and longitudinal studies examined
(Ramo, Liu, & Prochaska, 2012). Other recent studies show that hookah
(water pipe) use is similarly associated with greater marijuana use
among U.S. high school seniors and college students (Goodwin et al.,
2014; Palamar, Zhou, Sherman, &Weitzman, 2014). Emerging research
on e-cigarettes has documented an association between e-cigarette use
and use of alcohol, marijuana, and other illicit substances (Demissie,
Everett Jones, Clayton, & King, 2017; Westling, Rusby,
Crowley, & Light, 2017), although much of this research compares e-
cigarette use to cigarette use or dual use of both cigarettes and e-ci-
garettes (Dunbar et al., 2017; Kristjansson, Mann, & Smith, 2017;
McCabe, West, Veliz, & Boyd, 2017).
Similarly, the assessment of the association between youth tobacco
use and mental health problems is generally limited to cigarette
smoking. Studies suggest a positive association between youth tobacco
use and internalizing problems including depressive symptoms
(Lechner, Janssen, Kahler, Audrain-McGovern, & Leventhal, 2017;
Leventhal et al., 2016; Mistry, Babu, Mahapatra, &McCarthy, 2014;
Tercyak & Audrain, 2002) and anxiety (Marmorstein et al., 2010;
Marmorstein, White, Loeber, & Stouthamer-Loeber, 2010; Zehe, Colder,
Read, Wieczorek, & Lengua, 2013). Youth cigarette smoking has also
been associated with externalizing disorders involving disruptive be-
havior, including conduct disorder (Armstrong & Costello, 2002; Colder
et al., 2013; Leventhal et al., 2016; National Center for Chronic Disease
Prevention and Health Promotion (US) Office on and Smoking Health,
2012), oppositional defiant disorder, and attention-deficit/hyper-
activity disorder (ADHD) (Brinkman, Epstein, Auinger,
Tamm, & Froehlich, 2015; Elkins, McGue, & Iacono, 2007; Groenman
et al., 2013; S. S. Lee, Humphreys, Flory, Liu, & Glass, 2011). Moreover,
although two nationally representative studies found that youth poly-
tobacco use was associated with alcohol, marijuana, and other drug
disorders (Cavazos-Rehg, Krauss, Spitznagel, Grucza, & Bierut, 2014;
Richter, Pugh, Smith, & Ball, 2017), these did not focus on co-occurring
mental health problems.
Examining these associations across the full range of tobacco pro-
ducts used by American adolescents, a high-risk population for the
onset and exacerbation of tobacco use, substance use, and mental
health problems (Office of the Surgeon General, 2016;
Robinson & Riggs, 2016), is essential. Therefore, using Wave 1 data
from the Population Assessment of Tobacco and Health (PATH) Study,
the present study examined co-occurrence of substance use, substance
use problems, and mental health (internalizing and externalizing)
problems across 12 tobacco products. This study further examined these
associations by poly-tobacco use.
2. Methods
2.1. Study design and participants
The PATH Study is a nationally representative longitudinal study of
45,971 U.S. adults (18 years and older) and youth (12–17 years) de-
signed to examine tobacco use and health. This paper reports Wave 1
(September 2013–December 2014) data from 13,617 youth participants
with complete data on variables for the specific associations examined.
Participants were recruited via an address-based, area-probability
sampling approach, using an in-person household screener to select
youth from households that oversampled adult tobacco users, young
adults, and African-American adults. Generally, up to two youth were
sampled per household. The weighting procedures adjusted for over-
sampling and nonresponse, allowing estimates to be representative of
the non-institutionalized, civilian U.S. population. The weighted re-
sponse rate among sampled youth was 78.4%.
After obtaining consent from parents and emancipated youth and
assent from youth, data were collected using Audio-Computer Assisted
Self-Interviews administered in English or Spanish. Detailed methodo-
logical information about the study design and protocol is available
elsewhere (Hyland et al., 2017) and at http://www.icpsr.umich.edu/
icpsrweb/NAHDAP/series/606. The study was conducted by Westat
and approved by Westat's Institutional Review Board.
2.2. Measures
2.2.1. Tobacco use
Ever use of tobacco products was determined based on participants'
responses to questions on lifetime use (dichotomized as no = 0,
yes = 1) of the following: cigarettes, e-cigarettes, traditional cigars,
cigarillos, filtered cigars, pipe, hookah, smokeless tobacco (i.e. loose
snus, moist snuff, dip, spit, or chewing tobacco), snus pouches, kreteks,
bidis, and dissolvable tobacco. A brief description and pictures of each
product (except cigarettes) were shown to participants before being
asked about the products. Additional questions were asked of cigar
users to determine cigar type.
‘Any tobacco use’ was defined as ever using any tobacco product,
‘any cigar use’ was defined as ever using traditional cigars, cigarillos, or
filtered cigars, and ‘smokeless including snus’ was defined as ever using
smokeless tobacco or snus pouches. Among tobacco users, ‘poly-use’ of
any tobacco was defined as ever use of any two or more of the following
8 tobacco product categories: cigarettes, e-cigarettes, any cigar, pipe,
hookah, any type of smokeless tobacco (i.e., smokeless tobacco, snus
pouches or dissolvable tobacco), kreteks, and bidis, versus exclusive use
of any tobacco product, which was defined as ever use of only one of
these 8 tobacco product categories. ‘Poly-use’ of cigarettes was defined
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as ever use of cigarettes and ever use of at least one of the other 7
tobacco product categories, versus exclusive use of cigarettes, which
was defined as ever use of only cigarettes. ‘Poly-use’ of e-cigarettes was
defined as ever use of e-cigarettes and ever use of at least one of the
other 7 tobacco product categories, versus exclusive use of e-cigarettes,
which was defined as ever use of only e-cigarettes. For each poly-use
variable, complete data were required to categorize participants as
exclusive users, but were not required to categorize participants as
poly-users.
2.2.2. Substance use
Self-reported ever use was defined and dichotomized separately
(no = 0, yes = 1) as lifetime use of each of the following: alcohol,
marijuana (including blunts), misuse of prescription drugs (i.e. Ritalin®
or Adderall®; painkillers, sedatives, or tranquilizers), and other drugs
(cocaine or crack, stimulants (i.e. methamphetamine or speed), heroin,
inhalants, solvents, and hallucinogens).
In addition, ever use of alcohol or any drug was defined as the
lifetime use of any of the above substances (dichotomized as no = 0,
yes = 1). Substance use items in the PATH Study were adapted from
the National Epidemiologic Survey on Alcohol and Related Conditions
(National Instiutes of Health (NIH); National Institute on Alcohol Abuse
and Alcoholism (NIAAA), 2004–2005) and the National Health and
Nutrition Examination Survey (Centers for Disease Control and
Prevention (CDC); National Center for Health Statistics (NCHS),
2011–2012).
2.2.3. Substance use and mental health problems
Substance use and mental health problems were assessed via the
Global Appraisal of Individual Needs - Short Screener (GAIN-SS),
modified for the PATH Study (M. L. Dennis, Chan, & Funk, 2006). The
GAIN-SS identifies individuals at risk for mental health or substance use
disorders using a continuous measure of severity. Items for the GAIN-SS
were derived from the full GAIN instrument, a validated, standardized
biopsychosocial assessment for individuals entering treatment for sub-
stance use or mental health disorders (Garner, Belur, & Dennis, 2013)
and recommended for use in epidemiological samples by the PhenX
Toolkit (Hamilton et al., 2011). The PATH Study assessed severity
across three subscales: substance use problems, internalizing problems,
and externalizing problems. Table 1 displays the items and reliability
(Tavakol & Dennick, 2011) for each subscale.
The GAIN-SS measures problems across four time periods: past
month, 2–12 months ago, over a year ago, and never. Given the rela-
tively low proportions of youth substance use, the current study focused
on lifetime measures to maximize stability of the estimates. The number
of responses endorsed in the lifetime were summed for each subscale
(complete data for subscale components were required). Summary
scores ranged from 0 to 7 for substance use, 0–4 for internalizing, and
0–7 for externalizing problems. Based on the number of symptoms
endorsed, participants were categorized into three severity levels: no/
low (0–1 symptoms), moderate (2–3 symptoms), or high (4 for inter-
nalizing problems, or≥4 symptoms for substance use and externalizing
problems). These cut points were informed by previous studies showing
concurrent and predictive validity in other samples (M. L. Dennis, et al.,
2006; Garner, Belur, & Dennis, 2013). While individuals categorized as
no/low severity are unlikely to have a diagnosis or need services,
moderate severity indicates a possible diagnosis and need of services,
and high severity indicates high likelihood of a disorder and need for
services (M. Dennis, Feeney, Stevens, & Bedoya, 2006).
2.2.4. Covariates
Information was collected on socio-demographics characteristics
including age, gender, education, and race/ethnicity. Sensation
seeking, a risk factor for substance use (Hoyle, Stephenson, Palmgreen,
Lorch, & Donohew, 2002), was assessed via three modified items from
the Brief Sensation Seeking Scale: 1) “I like to do frightening things”, 2)
“I like new and exciting experiences even if I have to break the rules”,
and 3) “I prefer friends who are exciting and unpredictable” (Hoyle,
Stephenson, Palmgreen, Lorch, & Donohew, 2002). Response options
for each item (strongly agree, agree, neither agree nor disagree, dis-
agree, and strongly disagree) were summed to create an overall score
(range: 0–12) and mean score. The scale was found to be internally
consistent in the PATH Study (Cronbach's α= 0.76).
Table 1
GAIN-SS items and reliability.
GAIN-SS subscale Items Reliabilityf
Substance use problemsa,b 1) Used alcohol or other drugs weekly or more often
2) Spent a lot of time getting alcohol or other drugsc
3) Spent a lot of time using or recoveringc
4) Alcohol or drugs causing social problems, fights, or trouble with others
5) Reduced involvement with activities at work, school, home, or social events
6) Withdrawal problemsc
7) Use of alcohol or other drugs to stop being sick or avoid withdrawal problemsc
Lifetime = 0.85
Past year = 0.82
Internalizing problemsa,d 1) Feeling very trapped/sad/depressed
2) Trouble sleeping
3) Feeling nervous/anxious/tense/scared
4) Being distressed/upset about the past
Lifetime = 0.81
Past year = 0.79
Externalizing problemsa 1) Hard time paying attention
2) Hard time listening to instructions
3) Lied/conned to get something
4) Bullied/threatened people
5) Started a physical fight
6) Felt restless/need to climb on thingse
7) Gave answers before question was finishede
Lifetime = 0.77
Past year = 0.73
GAIN-SS: Global Appraisal of Individual Needs - Short Screener (GAIN-SS).
a Symptoms were categorized into no/low (0–1 symptoms), moderate (2–3 symptoms), and high (4 symptoms for internalizing problems or ≥4 symptoms for substance use and
externalizing problems) severity levels.
b Those who had never used alcohol or drugs were coded as having ‘0’ symptoms
c Items 2 and 3, as well as 6 and 7, were separated in the PATH Study.
d A fifth suicide item was not included in the PATH Study.
e Items 6 and 7 from the full GAIN Behavioral Complexity Scale were included in the PATH Study.
f Cronbach's α calculated for the PATH Study cutpoints.
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2.3. Analytic approach
Distributions of participants' demographic characteristics, tobacco
use, substance use, and substance use and mental health problems were
examined. All variables (except sensation seeking) were categorized for
analyses. For the aggregate variables (e.g. any tobacco use), complete
data were required to categorize participants as non-users, but not re-
quired to categorize participants as users.
Multivariable logistic regression evaluated the associations between
tobacco use and substance use, adjusting for socio-demographics
(Office of the Surgeon General, 2016) and sensation seeking. Due to
potential comorbidity between mental health problems and substance
use (Armstrong & Costello, 2002; Kessler et al., 2012), a combined
variable for lifetime mental health (internalizing and externalizing)
problems categorized as low/moderate (0–7 symptoms) and high (8–11
symptoms) was also included in the substance use regression models.
Multivariable logistic regression also modeled the odds of high versus
low/moderate substance use, internalizing, and externalizing problems
according to tobacco use, adjusting for socio-demographics and sensa-
tion seeking.
Distributions of alcohol or any drug use, the combined high severity
internalizing and externalizing problem measure, and high severity
substance use problems were also examined according to poly-tobacco
use. Multivariable logistic regression modeled the odds of alcohol or
any drug use according to poly-tobacco use, adjusting for socio-demo-
graphics, sensation seeking, and the combined variable for lifetime
mental health problems. Multivariable logistic regression also modeled
the odds of the combined high severity internalizing and externalizing
problem measure, and high severity substance use problems measure,
according to any poly-tobacco use, adjusting for socio-demographics
and sensation seeking. More detailed analyses can be found in the
supplement (see eTables 1 and 2).
Sensitivity analyses were conducted by repeating all analyses using
the complete-case method for handling missing data. Post hoc ex-
ploratory analyses were conducted to examine if gender moderated the
associations between tobacco use and substance use, as well as tobacco
use and substance use, internalizing, and externalizing problems.
Estimates were weighted to represent the U.S. youth population;
variances and confidence intervals (CIs) were estimated using the ba-
lanced repeated replication (BRR) method (McCarthy, 1969) with Fay's
adjustment set to 0.3 to increase estimate stability (Judkins, 1990).
Adjusted odds ratios (AORs) and 95% CIs were calculated for all re-
gression analyses. Two-sided p-values of< 0.05 were considered sta-
tistically significant. Estimates based on fewer than 50 observations in
the denominator or the relative standard error> 0.30 were suppressed
(Klein, Proctor, Boudreault, & Turczyn, 2002). All analyses were con-
ducted using Stata software, version 12 (StataCorp, 2011).
3. Results
3.1. Demographic and other characteristics
Approximately half of youth were between 12 and 14 years of age
(50.4%) and male (51.3%) (Table 2). A third (31.1%) reported ever use
of alcohol or any drug; alcohol (21.8%) and marijuana (13.4%) were
the most commonly used substances. The proportion of youth with high
severity of lifetime substance use problems was relatively low (3.9%),
while a larger proportion reported high severity of lifetime inter-
nalizing (33.8%) and externalizing (47.1%) problems. The sensation
seeking score ranged from 0 to 4 (mean (standard error (SE)) = 1.6
(1.1)).
3.2. Tobacco use and substance use
In multivariable analyses (Table 3), ever tobacco use was con-
sistently associated with a higher odds of ever substance use across all
tobacco products assessed. Tobacco users had nearly an 8-fold higher
odds of alcohol or any drug use (95% CI: 6.7–8.6) when compared to
non-users, after adjusting for socio-demographics, mental health pro-
blems, and sensation seeking. Across tobacco products, in comparison
to non-users of the respective products, odds of marijuana use was 15-
fold (95% CI: 12.4–17.2) for cigarettes, 10-fold for e-cigarettes (95% CI:
8.3–11.3), and 19-fold (95% CI: 15.3–23.4) for cigarillos. Associations
across tobacco products with other drug use were also statistically
significant and strong, with the strongest association at 19-fold (95%
CI: 13.1–27.6) for cigarettes.
Table 2
Demographic and other characteristics of PATH study wave 1 youth, 2013–2014.
Participant characteristics na %b SEb
Total 13,617 100.0 –
Age (years)c
12–14 6973 50.4 0.02
15–17 6642 49.6 0.02
Gender
Male 6949 51.3 0.03
Female 6630 48.7 0.03
Race/ethnicity
White, non-Hispanic 6463 54.6 0.07
Black, non-Hispanic 1798 13.7 0.06
American Indian/Alaska Native, non-Hispanic 70 0.4 0.07
Asian/Native Hawaiian/Other Pacific Islander, non-
Hispanic
392 4.7 0.07
Multiple races, non-Hispanic 767 4.2 0.08
Hispanic 3872 22.5 0.05
Education (grade in school)
5th grade or below 76 0.5 0.07
Middle school (grades 6–8) 5123 37.9 0.23
High school (grades 9–12) 7853 59.6 0.24
College, vocational/technical school 106 0.8 0.09
Not enrolled 32 0.2 0.04
Home-schooled 112 0.8 0.09
Ungradedd 14 0.1 0.03
Ever substance usee
Alcohol or any drug 4137 31.1 0.52
Alcohol 2914 21.8 0.52
Marijuana 1837 13.4 0.40
Ritalin/adderall 333 2.5 0.13
Painkillers/sedatives 1087 8.0 0.23
Other drugf 219 1.6 0.13
Lifetime substance use problemsg
No/low 11,943 90.6 0.31
Moderate 742 5.6 0.23
High 530 3.9 0.21
Lifetime internalizing problemsg
No/low 4865 36.5 0.53
Moderate 3956 29.7 0.46
High 4491 33.8 0.57
Lifetime externalizing problemsg
No/low 3407 25.7 0.57
Moderate 3538 27.2 0.43
High 6087 47.1 0.58
Sensation seeking scoreh
Mean (SE) 13,366 1.6 1.10
a Represents unweighted sample size (numbers may not sum to the total due to missing
data).
b Percentages (%) and standard errors (SE) are weighted to represent the US youth
population (N = 24,791,293).
c An age range between 12 and 17 years rather than a specific age was available for
two participants.
d School where students are not assigned to a particular grade.
e Categories are not mutually exclusive (i.e. percentages do not sum to 100%).
f Includes ever use of cocaine or crack, stimulants (i.e. methamphetamine or speed), or
heroin, inhalants, solvents, or hallucinogens.
g Lifetime substance use, internalizing and externalizing problems were assessed using
the Global Appraisal of Individual Needs - Short Screener (GAIN-SS) and categorized as
no/low (0–1 symptoms), moderate (2–3 symptoms), and high (4 symptoms for inter-
nalizing problems or ≥4 symptoms for substance use and externalizing problems) se-
verity levels.
h Assessed via three modified items from the Brief Sensation Seeking Scale.
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Although not systematic across tobacco products, gender moderated
several associations between tobacco use and substance use. In all cases
where this occurred, female tobacco users were more likely to use
substances than male tobacco users. Specifically, female cigarette users
were more likely than male cigarette users to use alcohol, marijuana,
and Ritalin/Adderall. Additionally, for any tobacco product, any cigar,
cigarillos, hookah, and smokeless tobacco (including snus pouches),
female users were more likely to use alcohol than their male counter-
parts.
3.3. Tobacco use and substance use and mental health problems
Multivariable logistic regression models (Table 4) showed strong
and consistent associations between ever tobacco use and high severity
lifetime substance use problems. Tobacco users had an almost 20-fold
(95% CI: 14.9–26.0) higher odds of substance use problems compared
to non-users. Across tobacco products, the strongest associations were
observed for cigarette (AOR = 14.7, 95% CI: 11.8–18.2), cigarillo
(AOR = 8.1, 95% CI: 6.3–10.3), and filtered cigar (AOR = 8.1, 95% CI:
5.7–11.5) users, compared to non-users of those products, respectively.
The magnitude of associations for internalizing and externalizing
problems varied by tobacco product, with ever cigarette, e-cigarette,
traditional cigar, cigarillo, and filtered cigar use each significantly as-
sociated with both internalizing and externalizing problems, after ad-
justing for socio-demographics and sensation seeking. The strongest
associations were observed for cigarette (AOR = 1.7, 95% CI: 1.5–2.0)
Table 4
High severity (%) of lifetime substance use, internalizing, and externalizing problems among ever tobacco users (Y) and non-users (N), PATH study, 2013–2014.
High severity substance use problemsa Mental health problems
High severity internalizing problemsa High severity externalizing problemsa
% (SE)b AOR (95% CI)c % (SE)b AOR (95% CI)c % (SE)b AOR (95% CI)c
Any tobacco
Y 16.0 (0.82) 19.7 (14.9–26.0) 48.3 (0.95) 1.6d (1.4–1.8) 61.3 (1.06) 1.4 (1.3–1.6)
N 0.6 (0.09) Referent 30.5 (0.66) Referent 43.8 (0.64) Referent
Cigarettes
Y 21.4 (1.18) 14.7 (11.8–18.2) 51.9 (1.28) 1.7d (1.5–2.0) 63.7 (1.27) 1.5 (1.3–1.7)
N 1.2 (0.10) Referent 31.3 (0.58) Referent 44.8 (0.60) Referent
E-cigarettes
Y 20.4 (1.22) 8.0 (6.5–9.9) 50.5 (1.41) 1.6d (1.3–1.8) 64.8 (1.38) 1.5 (1.3–1.7)
N 1.9 (0.14) Referent 32.1 (0.60) Referent 45.3 (0.59) Referent
Any cigar
Y 25.6 (1.57) 9.5 (7.4–12.3) 49.0 (1.39) 1.4d (1.2–1.7) 64.8 (1.64) 1.4d (1.2–1.7)
N 2.2 (0.17) Referent 33.0 (0.62) Referent 46.2 (0.58) Referent
Traditional cigars
Y 26.9 (2.89) 5.8 (4.1–8.3) 48.9 (3.03) 1.4 (1.1–1.9) 67.6 (3.07) 1.5 (1.1–2.1)
N 3.4 (0.20) Referent 33.9 (0.59) Referent 47.1 (0.57) Referent
Cigarillos
Y 25.7 (1.68) 8.1 (6.3–10.3) 48.4 (1.68) 1.4d (1.2–1.7) 64.3 (1.88) 1.4 (1.2–1.7)
N 2.4 (0.17) Referent 33.2 (0.61) Referent 46.3 (0.58) Referent
Filtered cigars
Y 34.3 (3.18) 8.1 (5.7–11.5) 56.0 (3.23) 1.7 (1.3–2.3) 70.8 (2.78) 1.8 (1.3–2.4)
N 3.2 (0.19) Referent 33.7 (0.58) Referent 47.0 (0.57) Referent
Pipe
Y 32.1 (3.53) 7.2 (5.0–10.6) 49.4 (3.79) 1.4 (1.0–1.9) 61.2 (3.96) 1.1 (0.7–1.6)
N 3.4 (0.19) Referent 33.8 (0.57) Referent 47.2 (0.58) Referent
Hookah
Y 22.7 (1.65) 6.4 (5.0–8.1) 47.5 (1.46) 1.2d (1.0–1.4) 59.1 (1.62) 1.1 (1.0–1.3)
N 2.4 (0.16) Referent 33.0 (0.61) Referent 46.4 (0.61) Referent
Smokeless (including snus pouches)
Y 18.8 (1.53) 4.7 (3.5–6.1) 43.5 (1.96) 1.2d (1.0–1.4) 61.9 (1.75) 1.2 (0.9–1.5)
N 3.2 (0.20) Referent 33.6 (0.58) Referent 46.7 (0.60) Referent
Smokeless (excluding snus pouches)
Y 18.6 (1.57) 4.3 (3.2–5.8) 44.5 (2.03) 1.2d (1.0–1.5) 62.2 (1.88) 1.2 (0.9–1.5)
N 3.2 (0.21) Referent 33.6 (0.58) Referent 46.7 (0.60) Referent
Snus pouches
Y 23.8 (3.48) 5.0 (3.3–7.7) 42.4 (3.33) 1.1 (0.8–1.5) 63.2 (3.35) 1.2 (0.9–1.7)
N 3.6 (0.20) Referent 33.9 (0.58) Referent 47.1 (0.59) Referent
Kreteks
Y 37.7 (7.28) † 48.4 (8.46) † 70.7 (6.53) †
N 3.8 (0.21) Referent 34.1 (0.57) Referent 47.4 (0.59) Referent
Bidis
Y † † † † † †
N 3.8 (0.21) Referent 34.1 (0.57) Referent 47.4 (0.59) Referent
Dissolvable
Y † NR † † † †
N 3.9 (0.22) Referent 34.1 (0.57) Referent 47.4 (0.59) Referent
Statistically significant associations at p < 0.05 indicated in bold text.
NR: estimates not reportable due to model convergence issues.
a Includes ever use of cocaine or crack, stimulants (i.e. methamphetamine or speed), or heroin, inhalants, solvents, or hallucinogens.
b Percentages (%) and standard errors (SE) are weighted to represent the US youth population.
c Adjusted Odds Ratios (AORs) and 95% confidence intervals (CIs) from multivariable logistic regression analyses adjusted for age, gender, race/ethnicity, lifetime mental health
(internalizing and externalizing) problem symptoms, and sensation seeking.
d Indicates gender interaction is significant at p < 0.05.
† Estimates with a denominator< 50 or relative standard error> 30% were suppressed.
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and filtered cigar (AOR = 1.7, 95% CI: 1.3–2.3) users for internalizing
problems, and filtered cigar users (AOR = 1.8, 95% CI: 1.3–2.4) for
externalizing problems. Results were virtually unchanged when ana-
lyses were repeated using the complete case method for handling
missing data.
Similar to the tobacco and substance use associations, a significant
gender-by-tobacco use interaction was seen across most tobacco pro-
duct use groups for internalizing problem associations, which were
stronger among female tobacco users than male tobacco users. In
comparison, no gender differences were found for substance use pro-
blems or externalizing problems, with the exception of female cigar
users being more likely to have externalizing problems than male cigar
users.
3.4. Poly-tobacco use and substance use and mental health problems
Fig. 1 presents the proportions of alcohol or any drug use, high
severity mental health problems, and high severity substance use pro-
blems among poly-tobacco users of any tobacco product versus ex-
clusive users of any tobacco product. Poly-tobacco users were more
likely to use alcohol or any drug than exclusive users (AOR = 3.4, 95%
CI: 2.7–4.3). Further, poly-tobacco users had a nearly 5-fold higher
odds (95% CI: 3.4–6.6) of having substance use problems in comparison
to exclusive tobacco users. While the prevalence of internalizing and
externalizing problems was higher among poly-tobacco users in com-
parison to exclusive users, the strength of the association was not as
pronounced as for substance use and substance use problems
(AOR = 1.2, 95% CI: 1.0–1.5). No significant gender interactions were
seen for these associations.
4. Discussion
This is one of few studies to comprehensively examine co-occur-
rence of substance use and mental health problems across tobacco-
product user groups and among poly-tobacco users in a nationally re-
presentative sample of U.S. youth. Findings indicate that youth tobacco
users, in comparison to non-users, are more likely to use substances and
have substance use problems. Moreover, these associations were robust
across the 12 tobacco products assessed, as well as for poly-tobacco use.
Tobacco users were also more likely to experience internalizing and
externalizing problems. Notably, gender moderated the associations
between tobacco use, substance use, and mental health problems. These
findings have important implications for understanding substance use
and mental health problems among youth tobacco users, as well as
emphasizing the need to address these comorbidities in clinical and
public health settings.
As documented previously (Ramo, Liu, & Prochaska, 2012; Richter
et al., 2017), our findings show robust tobacco and substance use as-
sociations across tobacco products, particularly between filtered cigar
and alcohol. The strong association between cigarillo and marijuana
use was also striking and may point to the simultaneous use of tobacco
and marijuana (e.g., blunts) as a risk pattern for continued use, ad-
diction and associated medical consequences (Bélanger et al., 2013;
Ramo et al., 2012). Considering the rapidly changing policies sur-
rounding marijuana legalization and the emergence of non-cigarette
tobacco products, the increased availability and use of these products
by youth (Johnston, O'Malley, Miech, Bachman, & Schulenberg, 2017)
represent a public health concern that warrants further attention.
Results were equally striking for associations between tobacco
product use and substance use problems. The strongest association for
substance use problems was found among cigarette users, which sug-
gests that cigarette use may be a clinically useful indicator of proble-
matic substance use (Office of the Surgeon General, 2016). This study
also demonstrates that users of e-cigarettes, traditional cigars, cigar-
illos, filtered cigars, hookah, and smokeless tobacco are more likely to
experience internalizing problems compared to their non-using
counterparts, thereby extending prior research that focused primarily
on cigarette smoking (Marmorstein et al., 2010; Marmorstein, White,
Loeber, et al., 2010; Mistry, Babu, Mahapatra, &McCarthy, 2014; Zehe,
Colder, Read, Wieczorek, & Lengua, 2013). While the association be-
tween cigarette use and externalizing problems has been established
among youth (Armstrong & Costello, 2002; Colder et al., 2013; National
Center for Chronic Disease Prevention and Health Promotion (US)
Office on and Smoking Health, 2012), this study extends the literature
for youth filtered cigar, e-cigarette, traditional cigar, and cigarillo users.
Our finding of increased risk regardless of tobacco product points to
nicotine as a common denominator of potential etiological significance
in understanding the interplay between mental health and substance
use problems. However, we cannot rule out that these associations may
also be driven by a shared environmental, familial, or genetic diathesis
representing a common underlying factor for tobacco use, substance
use, and mental illness. Future analysis of the PATH Study's long-
itudinal data can examine whether youth who use tobacco products are
more or less likely to develop or exacerbate mental health problems.
Additionally, consistent with recent findings using 2014 data from
the National Survey on Drug Use and Health (NSDUH) and the
Monitoring the Future (MTF) study (Richter et al., 2017) and extending
to mental health problems, poly-tobacco users were more likely to use
alcohol and drugs and have substance use and mental health problems
than exclusive tobacco users. Although these comorbidities are fre-
quently documented, few prevention and intervention strategies ad-
dress tobacco use within the same framework as substance use and
mental health. Given the high prevalence of poly-tobacco use (Kasza
et al., 2017; Richter et al., 2017; Villanti et al., 2016) and poly-sub-
stance use (Connor, Gullo, White, & Kelly, 2014) among youth, our
findings support and reinforce the need for timely and comprehensive
interventions and treatment that effectively address these co-occurring
conditions (Camenga & Klein, 2016).
While exploratory, the gender differences in tobacco, substance use,
and mental health comorbidities observed in this study warrant further
attention. In all occurrences of gender-by-tobacco use interactions, fe-
male tobacco users were more likely to use substances than male to-
bacco users, particularly for cigarette users. Associations with alcohol
use were also stronger for female non-cigarette tobacco product users
compared to their male counterparts and across tobacco products, fe-
male users were more likely to have internalizing problems than males.
These findings are consistent with the co-occurrence of these behaviors


















Alcohol or Any Drug (%) High Severity Internalizing and
Externalizing Problems* (%)
High Severity Substance Use
Problems**(%)
      Poly tobacco use
      Exclusive tobacco use
Chi2 =  7.0, p=0.009
AOR = 1.2, 95% CI: 1.0-1.5
Chi2 =  155.0, p<0.001
AOR = 3.4, 95% CI: 2.7-4.3
Chi2 = 123.2, p<0.001 
AOR = 4.7, 95% CI: 3.4-6.6
Fig. 1. Ever substance use (%) and lifetime high severity mental health problems (%)
among youth poly-tobacco ever users versus exclusive ever tobacco users, PATH study,
2013–2014.
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product users may be on an increased trajectory of risk for substance
use and mental health problems beginning in adolescence, and effective
interventions and treatment tailored to females are critical at a young
age to prevent these disparities persisting into adulthood.
Although Wave 1 data from the PATH Study are nationally re-
presentative, harmonized with other national studies, and focus on
multiple tobacco products, this study has limitations. The GAIN-SS
measures severity of mental-health symptomology rather than diag-
nosis. However, the high sensitivity and specificity between GAIN-SS
items and diagnoses supports the use of symptoms as good indicators of
clinically significant mental-health problems (M. L. Dennis, et al.,
2006). Additionally, some items from the GAIN-SS were omitted from
the PATH Study's Wave 1 instrument, thereby limiting the ability to
assess their associations with tobacco use. Given the instrument design,
we were not able to assess whether cigarillo users were also using ci-
garillos modified as a blunt at the same time or other instances, po-
tentially explaining the large odds ratios observed for those associa-
tions. Furthermore, while testing interactions with demographic
variables aside from gender were beyond the scope of this study, future
studies may explore comorbidities across different subgroups defined
by demographics (e.g., age, race/ethnicity), which can provide addi-
tional insight into the associations observed in this study. Finally, while
the cross-sectional Wave 1 data preclude the establishment of tempor-
ality, future longitudinal data of the PATH Study will help clarify the
temporal ordering between youth tobacco use, substance use, and
substance use and mental health problems.
5. Conclusions
The present study documents high co-occurrence of alcohol and
drug use, as well as substance use and mental health problems, across
tobacco products in a nationally representative sample of U.S. youth.
These findings also point to youth tobacco use, especially cigarette and
poly-tobacco use, as a potential indicator of treatment need for sub-
stance use problems. Researchers and health-care providers should
consider comprehensive assessments of tobacco use, substance use, and
mental health problems to identify vulnerable youth for prevention and
early intervention efforts, and effective treatments should take into
account and address these comorbidities.
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